GetTopicDetailResponse(id=75771122236f, topicName=2期研究, introduction=2期研究, content=曲美替尼 上皮樣血管內(nèi)皮瘤 2期研究, image=null, comments=0, allHits=922, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Mar 13 09:32:01 CST 2024, time=2024-03-13, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=488175, tagList=[TagDto(tagId=488175, tagName=2期研究)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2221279, encodeId=8b5f22212e9be, content=<a href='/topic/show?id=f60f118092e1' target=_blank style='color:#2F92EE;'>#復(fù)發(fā)性或難治性濾泡性淋巴瘤#</a> <a href='/topic/show?id=75771122236f' target=_blank style='color:#2F92EE;'>#2期研究#</a> <a href='/topic/show?id=585b1180938d' target=_blank style='color:#2F92EE;'>#奧尼妥單抗#</a>, objectTitle=Ann. Oncol | 2期研究：奧尼妥單抗在治療復(fù)發(fā)或難治性濾泡性淋巴瘤患者中表現(xiàn)出顯著療效和安全性, objectType=article, longId=839537, objectId=5a1b83953efa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240818/1723987197001_6145188.png, objectUrl=/article/show_article.do?id=5a1b83953efa, replyNumber=0, likeNumber=62, createdTime=2024-08-19, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5a1b83953efa, moduleTitle=Ann. Oncol | 2期研究：奧尼妥單抗在治療復(fù)發(fā)或難治性濾泡性淋巴瘤患者中表現(xiàn)出顯著療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5a1b83953efa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2192903, encodeId=75a4219290334, content=<a href='/topic/show?id=4b0e60250e2' target=_blank style='color:#2F92EE;'>#曲美替尼#</a> <a href='/topic/show?id=58bd108e222e' target=_blank style='color:#2F92EE;'>#上皮樣血管內(nèi)皮瘤#</a> <a href='/topic/show?id=75771122236f' target=_blank style='color:#2F92EE;'>#2期研究#</a>, objectTitle=Clin Cancer Res：曲美替尼治療局部晚期或轉(zhuǎn)移性上皮樣血管內(nèi)皮瘤患者的單臂2期研究, objectType=article, longId=816912, objectId=ea73816912e4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/pexels-photo-208541.jpeg, objectUrl=/article/show_article.do?id=ea73816912e4, replyNumber=0, likeNumber=127, createdTime=2024-03-13, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ea73816912e4, moduleTitle=Clin Cancer Res：曲美替尼治療局部晚期或轉(zhuǎn)移性上皮樣血管內(nèi)皮瘤患者的單臂2期研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ea73816912e4)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-03-13發(fā)表于上海
